GH insiders

19 insiders have filed at GH since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Talasaz AmiraliCo-Chief Executive Officer4.27M3.253%18 sells $27.5M
Eltoukhy HelmyCo-Chief Executive Officer4.20M3.202%4 sells $27.2M
Eagle CraigChief Medical Officer66.4k0.051%
Chudova DaryaChief Technology Officer64.4k0.049%3 sells $3.0M
Saia John G.Chief Legal Officer56.9k0.043%1 sells $866k
Freeman ChrisChief Commercial Officer53.6k0.041%11 sells $3.2M
Kalia KumudChief Information Officer44.3k0.034%1 buys $39k9 sells $4.9M
Bell Michael BrianChief Financial Officer43.6k0.033%13 sells $8.5M
Merrill AmeliaSVP, People27.5k0.021%
Gadde VijayaDirector24.3k0.019%
Monroe Terilyn J.Chief People Officer21.0k0.016%13 sells $7.9M
Krognes Steve E.Director19.1k0.015%
Potter Myrtle SDirector18.3k0.014%6 sells $138k
Joyce Meghan V.Director11.2k<0.01%10 sells $274k
Clark Ian TDirector9.9k<0.01%6 sells $3.6M
Tariq MusaDirector8.4k<0.01%15 sells $349k
Mignone RobertoDirector4.5k<0.01%
Hidalgo Medina ManuelDirector1.4k<0.01%7 sells $510k
Azar Alex M IIDirector

Full register at boothcheck.com/insiders/GH. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

GH institutional holders · GH research report